News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Hard-to-treat pancreatic cancer hijacks immune system and could be targeted with immunotherapies
Scientists have used artificial intelligence to reveal an aggressive form of pancreatic cancer that is more likely to respond to immunotherapy, in the most extensive analysis of the immune landscape of these tumours to date.
Teaching evolutionary theory to artificial intelligence reveals cancer’s life history
Scientists have developed the most accurate computing method to date to reconstruct the patchwork of genetic faults within tumours and their history during disease development.
Kick-starting the ICR: an interview with PhD student Iona Black
As our #KickstartICR appeal draws to a close, we spoke to PhD student Iona Black about her research and the importance of fundraising for cancer research.
ICR research ranks in top five globally for academic influence, collaboration and commercial impact
The Institute of Cancer Research has again ranked among the top higher education institutions in the world for the impact of our research academically and commercially.
Scientists discover three new genetic variants linked to male breast cancer
UK scientists have discovered three new genetic changes that increase the risk of breast cancer in men, in the world’s largest genetic study of the causes of male breast cancer to date.
Computer-assisted ultrasound imaging could help deliver more accurate radiotherapy for prostate cancer
A computer algorithm which helps radiographers interpret ultrasound images could improve radiotherapy treatment for patients with prostate cancer, a new study suggests.
Immune system could be trained to spot drug-resistant cancers
Aggressive cancers could be treated with immunotherapies that direct the immune system to kill cancer cells with specific drug resistance-causing mutations, a major new study suggests.
Study strengthens calls to clear cancer diagnosis backlog
Delays to cancer referral through reduced use of the urgent GP referral pathway during the coronavirus pandemic could result in more than a thousand additional deaths in England, a new study reports.
Long-term safety of radiotherapy in fewer doses for patients with early breast cancer demonstrated in 10-year study
A lower total dose of radiotherapy delivered in fewer but larger doses is as safe in the long term as breast cancer radiotherapy courses giving multiple small doses, according to the final results of a 10-year study.
Urgent call to kick-start life-saving cancer research so cancer patients don’t get left behind
Scientists researching new treatments for cancer patients are calling for urgent support to ensure the disruption caused by the coronavirus crisis does not damage long-term progress to defeat the disease.
Researchers reveal discovery of new cancer drug fadraciclib
Scientists have revealed details of the discovery of a new cancer drug that could be used to treat a range of cancer types, including some blood cancers and solid tumours.
Lung cancer in non-smokers likely to respond differently to treatment
Lung cancer in non-smokers is a biologically distinct disease from that in smokers, according to a new study. Researchers also found it has characteristics that mean it could be targeted with tailored treatments.
